Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) was among Tuesday's worst performers, with its shares dropping 3.83%. The broader market also saw muted gains. RXRX welcomed new board members, ranking 9th on the worst performers list.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing